XORTX Therapeutics (NASDAQ:XRTX) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened

XORTX Therapeutics Inc. (NASDAQ:XRTX)’s stock price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.21 and traded as high as $2.28. XORTX Therapeutics shares last traded at $2.07, with a volume of 175,408 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of XORTX Therapeutics in a research report on Wednesday, June 24th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, XORTX Therapeutics has an average rating of “Sell”.

XORTX Therapeutics Trading Down 2.4%

The company has a market cap of $3.34 million, a price-to-earnings ratio of -0.67 and a beta of 0.75. The company has a fifty day moving average price of $2.13 and a two-hundred day moving average price of $2.21.

XORTX Therapeutics (NASDAQ:XRTX) last issued its earnings results on Saturday, August 15th. The technology company reported ($1.05) EPS for the quarter.

About XORTX Therapeutics

Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers.